Advertisement
News
Advertisement

Vital Therapies delays IPO on 'poor market conditions'

Fri, 11/22/2013 - 2:20pm
Mass Device

California biotherapeutics company Vital Therapies puts off its initial public offering due to sluggishness in the market, with no new date yet selected.

Vital Therapies delays IPO on 'poor market conditions'

San Diego, Calif.-based Vital Therapies Inc. decided to put off its initial public offering for an undisclosed period of time, hoping market conditions will improve for its liver failure cell-based therapy.

The IPO was supposed to launch this week, according to Renaissance Capital IPO Center, which cited "poor market conditions" as the reason for the delay.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading